1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with benzaldehyde in 1 studies
*benzaldehyde: RN given refers to parent cpd; structure [MeSH]
*benzaldehyde: RN given refers to parent cpd; structure [MeSH]
| Studies (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Trials (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Studies (benzaldehyde) | Trials (benzaldehyde) | Recent Studies (post-2010) (benzaldehyde) |
|---|---|---|---|---|---|
| 195 | 3 | 161 | 868 | 3 | 359 |
| Protein | Taxonomy | 1,4,7-triazacyclononane-n,n',n''-triacetic acid (IC50) | benzaldehyde (IC50) |
|---|---|---|---|
| Chain B, SARS CORONAVIRUS MAIN PROTEINASE | Severe acute respiratory syndrome-related coronavirus | 5 | |
| Botulinum neurotoxin type A | Clostridium botulinum | 2.9 | |
| Cytochrome P450 2A6 | Homo sapiens (human) | 3.92 | |
| Cytochrome P450 2A5 | Mus musculus (house mouse) | 3.28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arukwe, J; Bhalla, R; Danikas, A; Glaser, M; Hiscock, D; Hoppmann, S; Indrevoll, B; Iveson, P; Wilson, A | 1 |
1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and benzaldehyde
| Article | Year |
|---|---|
Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment.
Topics: Animals; Benzaldehydes; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Positron-Emission Tomography; Protein Binding; Radiochemistry; Receptor, ErbB-2; Recombinant Fusion Proteins; Silicon; Tomography, X-Ray Computed | 2013 |